B and T cell immunity in MS with anti-CD20 therapy: Gene expression and protein profiles

被引：0
|
作者：
Fong, C. [1 ]
Spencer, J. [1 ]
Howlett-Prieto, Q. [1 ]
Park, G. [1 ]
Feng, X. [1 ]
Reder, A. [1 ]
机构：
[1] Univ Chicago, Neurol, Chicago, IL USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P614
引用
收藏
页码：535 / 535
页数：1
相关论文
共 50 条
  • [1] Impact on innate immunity of anti-cd20 therapy for ms
    Corbisiero, Silvia
    Guerrera, Gisella
    D'Orso, Silvia
    Picozza, Mario
    Pirronello, Marta
    Verdiani, Alice
    Angelini, Daniela
    Tortorella, Carla
    Ruggieri, Serena
    Giulietti, Giovanni
    Gasperini, Claudio
    Borsellino, Giovanna
    Battistini, Luca
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 969 - 970
  • [2] Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles
    Fong, Chloe C. C.
    Spencer, Julian
    Howlett-Prieto, Quentin
    Feng, Xuan
    Reder, Anthony T.
    [J]. FRONTIERS IN NEUROLOGY, 2023, 14
  • [3] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Taylor, Ronald P.
    Lindorfer, Margaret A.
    Zent, Clive S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 876 - 877
  • [4] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21): : 2008 - 2016
  • [5] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    [J]. RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [6] Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles (vol 14, 1158487, 2023)
    Fong, Chloe C.
    Spencer, Julian
    Howlett-Prieto, Quentin
    Feng, Xuan
    Reder, Anthony T.
    [J]. FRONTIERS IN NEUROLOGY, 2023, 14
  • [7] B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
    Shaw, T
    Quan, J
    Totoritis, MC
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 55 - 59
  • [8] Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression
    Davis, TA
    Czerwinski, DK
    Levy, R
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (03) : 611 - 615
  • [9] Unraveling the T-B tangle in anti-CD20 multiple sclerosis therapy
    Waisman, Ari
    Ebering, Anna
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (51) : 25376 - 25377
  • [10] T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma
    Vincent-Salomon, A
    Mathiot, C
    MacIntyre, E
    Girre, V
    Fourquet, A
    Mercier, C
    Fréneaux, P
    Dumont, J
    Decaudin, D
    [J]. LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 387 - +
12345